Letters to the Editor

Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, University Hospitals of Cleveland, Cleveland, OH, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Haematologica Early view Apr 16, 2020 https://doi.org/10.3324/haematol.2020.249649